QID 378427

QID 378427: Oracle PeopleSoft Enterprise PeopleTools Product Multiple Vulnerabilities (CPUAPR2023)

Oracle's PeopleSoft applications are designed to address the most complex business requirements. PeopleSoft PeopleTools provides a comprehensive development toolset that supports the development and runtime of PeopleSoft applications.

Affected Versions:
Oracle PeopleSoft Enterprise PeopleTools 8.58
Oracle PeopleSoft Enterprise PeopleTools 8.59
Oracle PeopleSoft Enterprise PeopleTools 8.60

QID Detection Logic (Authenticated):
The authenticated check looks for the installed version of PeopleTools and the corresponding patch. Note: For CVE-2020-14343 only Oracle PeopleSoft Enterprise PeopleTools 8.58 and 8.59 are impacted For CVE-2022-34169 only Oracle PeopleSoft Enterprise PeopleTools 8.58 and for CVE-2022-45047 only Oracle PeopleSoft Enterprise PeopleTools 8.60 are impacted

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as Critical - 10 severity.
    • Solution
    Newer versions are available to download. For more information about this product or to check for new releases, go to the PeopleSoft Enterprise PeopleTools .
    Vendor References

    CVEs related to QID 378427

    CVE-2020-14343 | CVE-2022-45047 | CVE-2022-41881 | CVE-2022-34169 | CVE-2022-45685 | CVE-2021-37533 | CVE-2022-36033 | CVE-2023-21916 | CVE-2023-21981 |
    Software Advisories
    Advisory ID Software Component Link
    CPUAPR2023 URL Logo www.oracle.com/security-alerts/cpuapr2023.html#AppendixPS
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].